CureVac N.V. (BIT:1CVAC)

Italy flag Italy · Delayed Price · Currency is EUR
2.504
0.00 (0.00%)
At close: Apr 17, 2025, 5:30 PM CET
-18.96%
Market Cap 627.88M
Revenue (ttm) 535.18M
Net Income (ttm) 162.19M
Shares Out n/a
EPS (ttm) 0.72
PE Ratio 3.87
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 435
Open 2.504
Previous Close 2.504
Day's Range 2.504 - 2.504
52-Week Range 2.128 - 4.952
Beta n/a
RSI 32.43
Earnings Date Apr 25, 2025

About CureVac

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company’s portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology instructs human cells to produce or secrete specific proteins in the nucleus, cytoplasm, cellular organelles, and cell membrane. In additi... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 983
Stock Exchange Borsa Italiana
Ticker Symbol 1CVAC
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.